resveratrol has been researched along with etoposide in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (50.00) | 29.6817 |
2010's | 9 (45.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Baruchello, R; Bonora, C; Buscemi, F; Grimaudo, S; Pizzirani, D; Roberti, M; Rondanin, R; Simoni, D; Tolomeo, M | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Dai, F; Fan, GJ; Fang, JG; Jin, XL; Li, XZ; Liu, XD; Qian, YP; Shang, YJ; Zhou, B | 1 |
Cai, YJ; Fan, GJ; Fang, JG; Li, XZ; Qian, YP; Wei, QY; Yang, J; Zheng, LF; Zhou, B | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Cheng, LX; Dai, F; Jin, XL; Li, XZ; Luo, H; Qian, YP; Tang, JJ; Yang, J; Zhou, B | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Huang, J; Jiang, S; Li, N; Li, X; Wang, JH; Wang, Y; Xiao, W; Zhang, P | 1 |
Mahyar-Roemer, M; Roemer, K | 1 |
Ackermann, S; de Oliveira Franz, CB; Drews, G; Grenz, A; Hambrock, A; Hiller, S; Osswald, H; Schulze, DU | 1 |
Hwang, JT; Kim, HM; Kim, YM; Kwak, DW; Lin, SK; Park, OJ | 1 |
Bickenbach, KA; Kron, SJ; Mauceri, HJ; Posner, MC; Shao, MY; Veerapong, J; Weichselbaum, RR | 1 |
Amiri, F; Jeddi-Tehrani, M; Koohdani, F; Vafa, M; Zand, H; Zarnani, AH | 1 |
Bigenzahn, J; Brunner, M; Heiduschka, G; Houben, R; Lill, C; Schmid, R; Seemann, R; Thurnher, D | 1 |
Bigenzahn, J; Brunner, M; Heiduschka, G; Thurnher, D | 1 |
Chang, PY; Chen, CY; Chen, JC; Jian, YJ; Jian, YT; Ko, JC; Lin, YW; Syu, JJ; Wang, TJ | 1 |
Beck, JF; Becker, S; Blümel, L; Blumrich, A; Kahl, M; Krämer, OH; Siranjeevi, PM; Sonnemann, J; Winkler, R; Wittig, S | 1 |
Cao, S; Chen, B; Sui, X; Tang, F; Wang, S; Xu, C; Yin, L; Zhang, C; Zhi, X; Zhou, J | 1 |
Contreras-Ochoa, CO; Díaz-Chávez, J; Lagunas-Martínez, A; López-Arellano, ME; Madrid-Marina, V; Moreno-Banda, GL; Munguía-Moreno, JA; Reyna-Figueroa, J; Roblero-Bartolon, G | 1 |
20 other study(ies) available for resveratrol and etoposide
Article | Year |
---|---|
Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
Topics: Antineoplastic Agents; Apoptosis; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Isomerism; Resveratrol; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
4,4'-Dihydroxy-trans-stilbene, a resveratrol analogue, exhibited enhanced antioxidant activity and cytotoxicity.
Topics: Antioxidants; Cell Line, Tumor; Drug Screening Assays, Antitumor; Erythrocyte Membrane; Humans; Kinetics; Lipid Peroxidation; Magnetic Resonance Spectroscopy; Oxidation-Reduction; Resveratrol; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Stilbenes | 2009 |
Antioxidant-based lead discovery for cancer chemoprevention: the case of resveratrol.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Apoptosis; Cations, Divalent; Cell Survival; Copper; DNA Damage; HL-60 Cells; Humans; Hydrogen Peroxide; In Vitro Techniques; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; Oxidants; Reactive Oxygen Species; Resveratrol; Stilbenes; T-Lymphocytes | 2009 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Antioxidant and antiproliferative activities of hydroxyl-substituted Schiff bases.
Topics: Antioxidants; Cell Line, Tumor; Cell Proliferation; DNA Damage; Electrophoresis, Agar Gel; Humans; Schiff Bases; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Bioactive barrigenol type triterpenoids from the leaves of Xanthoceras sorbifolia Bunge.
Topics: Molecular Structure; Plant Leaves; Sapindaceae; Triterpenes | 2013 |
p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
Topics: Adenocarcinoma; Alleles; Amino Acid Chloromethyl Ketones; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Benzothiazoles; Butyrates; Cisplatin; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Proteinase Inhibitors; Demecolcine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Neoplasm Proteins; Recombination, Genetic; Resveratrol; Stilbenes; Thiazoles; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner.
Topics: Animals; Apoptosis; ATP-Binding Cassette Transporters; Caspases; Cell Adhesion; Cell Line; Etoposide; Female; Humans; Hypoglycemic Agents; Islets of Langerhans; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Recombinant Proteins; Resveratrol; Stilbenes; Sulfonylurea Receptors; Transfection | 2007 |
Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Drug Resistance, Neoplasm; Etoposide; HT29 Cells; Humans; Multienzyme Complexes; Protein Serine-Threonine Kinases; Resveratrol; Signal Transduction; Stilbenes | 2007 |
Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy.
Topics: Acetylation; Adenoviridae; Animals; Blotting, Western; Cell Line, Tumor; Early Growth Response Protein 1; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Mice; Mice, Nude; Rats; Resveratrol; Sirtuins; Stilbenes; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2008 |
Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2013 |
The effect of resveratrol in combination with irradiation and chemotherapy: study using Merkel cell carcinoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Cell Line, Tumor; Cell Survival; Chemoradiotherapy; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Humans; Resveratrol; Stilbenes; Treatment Outcome | 2014 |
Resveratrol synergistically enhances the effect of etoposide in HNSCC cell lines.
Topics: Analysis of Variance; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Flow Cytometry; Head and Neck Neoplasms; Humans; Reference Values; Resveratrol; Squamous Cell Carcinoma of Head and Neck; Stilbenes | 2014 |
Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; RNA Interference; Signal Transduction; Stilbenes; Time Factors; Transfection; X-ray Repair Cross Complementing Protein 1 | 2015 |
Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Caspases; Cell Proliferation; Etoposide; Flow Cytometry; Heterocyclic Compounds, 4 or More Rings; Humans; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma, Ewing; Sirtuin 1; Stilbenes; Tumor Cells, Cultured; Vincristine | 2016 |
Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Lymphoma, Extranodal NK-T-Cell; Mitochondria; Resveratrol; Stilbenes | 2017 |
Molecular mechanisms of cell death induced in glioblastoma by experimental and antineoplastic drugs: New and old drugs induce apoptosis in glioblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytes; Caspases; Cell Line, Tumor; Cell Survival; Cisplatin; Etoposide; Glioblastoma; Humans; Leupeptins; Mice; Resveratrol; Tumor Suppressor Protein p53 | 2020 |